slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 62,581-62,610
Pages 2,605
Rows per page 30
Component
62,581-62,610 of 78,138
27
The chart tracks Gross Leverage (Debt / LTM EBITDA) from Feb 2022 to May 2023, showing a decline from 3.9x to 2.2x.Factset | Investor Presentation Deck | 37 slides · FactSet
Conference presentation Investor relations Beat · Financials1 hit
03
The slide uses a line chart to visualize the immediate negative market reaction to the financing announcement.Freeman Capital Management | Activist Presentation Deck | 15 slides · Freeman Capital Management
Activist deck Activist investor Beat · The Monster (ISS and MindMed's flaws)1 hit
04
Uses a red X to visually invalidate the ISS projection point.Freeman Capital Management | Activist Presentation Deck | 15 slides · Freeman Capital Management
Activist deck Activist investor Beat · The Monster (ISS and MindMed's flaws)1 hit
05
Uses statistical argument (structural vector auto-regression) to debunk a proxy advisor's narrative.Freeman Capital Management | Activist Presentation Deck | 15 slides · Freeman Capital Management
Activist deck Activist investor Beat · The Monster (ISS and MindMed's flaws)1 hit
10
Uses a two-column layout to contrast specific claims with 'Reality' checks.Freeman Capital Management | Activist Presentation Deck | 15 slides · Freeman Capital Management
Activist deck Activist investor Beat · The Monster (ISS and MindMed's flaws)1 hit
15
The slide uses a bar chart to contrast spending categories and a timeline to illustrate the clinical trial path.Freeman Capital Management | Activist Presentation Deck | 15 slides · Freeman Capital Management
Activist deck Activist investor Beat · The Victory (Freeman Capital Management's goal)Loop · The Reveal1 hit
11
The chart shows a dual-axis representation of production volume (bars) and line speed (line).Freyr | Investor Day Presentation Deck | 29 slides · FREYR
Conference presentation Investor relations Beat · Satisfaction1 hit
12
Uses a before-after comparison to illustrate process simplification and CAPEX reduction.Freyr | Investor Day Presentation Deck | 29 slides · FREYR
Conference presentation Investor relations Beat · Satisfaction1 hit
23
The chart is a waterfall-style buildup of capacity (GWh) for Giga America.Freyr | Investor Day Presentation Deck | 29 slides · FREYR
Conference presentation Investor relations Beat · Satisfaction1 hit
03
The slide uses a combination of big-number metrics and a combo chart (bar + line) to show financial health.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Attention1 hit
06
The slide uses a 2x2 grid layout to categorize strategic pillars.Honest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · Key Messages1 hit
09
The slide highlights the 'Balanced Omni-Channel Model' of the company.Honest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · KPI OverviewLoop · Pareto Focus1 hit
11
The chart illustrates that Diapers & Wipes are the primary revenue driver at 64%.Honest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · KPI OverviewLoop · Pareto Focus1 hit
12
Includes visual examples of exclusive prints and product packaging.Honest | Investor Conference Presentation Deck | 19 slides · The Honest Company
Conference presentation Investor relations Beat · KPI OverviewLoop · Pareto Focus1 hit
05
Slide 4 of a presentation, likely HSBC given the branding.HSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations Beat · What Could BeLoop · Voice Of Customer1 hit
06
HSBC | Investor Event Presentation Deck | 10 slidesHSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations Beat · New Bliss1 hit
08
The slide uses a donut chart visual to represent the sales mix of the portfolio.Kering | Mergers and Acquisitions Presentation Deck | 15 slides · Kering
Deck Investment bank 1 hit
07
The slide uses a Gantt-style chart to show the progression of various drug programs (IRAK4, IRAKIMiD, STAT3, MDM2, etc.) through discovery, IND enabling, and clinical phases.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
17
The chart shows a clear reduction in IRAK4 protein levels in both AD and HS patient groups after 28 days of treatment, bringing them down to or below the baseline levels of healthy subjects.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
19
The chart specifically visualizes IL-6 reduction over time, while the table summarizes max reduction across four markers.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
20
The slide uses individual patient data points (AD-1 to AD-7, HS-1 to HS-12) to show consistent downregulation across cohorts.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
22
The chart tracks patient outcomes over time, showing a shift from severe/moderate to mild categories.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
28
Includes clinical efficacy table and RNAseq biomarker reduction chart.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
29
Includes patient profile, clinical efficacy table, before/after photos, and cytokine biomarker tracking.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
32
Data presented as mean change from baseline with 90% CI. Includes table of mean values for delta QTc and absolute QTc.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
38
Data presented for Cycle 1; DL4 shows mean values for n=2 patients.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
39
Includes a disclaimer/footnote regarding patient population and MYD88 mutation status.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
46
Includes a line chart for PK profiles and a table for PK parameters (Cmax, AUClast, Vd, CL, t1/2).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
47
The slide presents clinical trial results for KT-333, comparing degradation percentages across three dose levels (DL1, DL2, DL3) over two cycles.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
51
Includes a DepMap CRISPR sensitivity plot and a biological pathway diagram illustrating the feedback loop.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit